National Drug Distribution Guidelines (2nd Edition) 2012

Guidelines set standards for the distribution of pharmaceutical products in Nigeria, ensuring safe storage and supply chain integrity. They target manufacturers, pharmacies, and drug regulators to maintain medicine quality. This helps deliver safe drugs to all Nigerians.

What Is This Policy?

Regulatory guidelines governing the distribution of pharmaceutical products in Nigeria, establishing standards for supply chain integrity, storage conditions, and distribution practices to ensure that safe, quality medicines reach end users.

Who Does It Target?

Pharmaceutical manufacturers and importers Wholesale and retail pharmacies Hospital pharmacy departments Drug regulatory officers and inspectors

What Does It Aim to Achieve?

Maintain the quality and safety of pharmaceutical products throughout the distribution chain by setting clear standards for storage, transportation, record-keeping, and good distribution practices.

Key Features

Good Distribution Practice: Standards for warehousing, transportation, and handling of pharmaceutical products Cold Chain Requirements: Specific protocols for temperature-sensitive medicines including vaccines Record-Keeping: Documentation requirements for traceability from manufacturer to patient Anti-Counterfeiting Measures: Verification steps to prevent counterfeit and substandard medicines from entering the supply chain Inspection and Compliance: Regular audits and inspection frameworks for distribution outlets

Current Status

Rollout Stage: Active and enforced by NAFDAC Coverage: All pharmaceutical distribution channels nationwide Lead Agency: NAFDAC (National Agency for Food and Drug Administration and Control) Enforcement: NAFDAC inspection teams and Pharmacists Council of Nigeria

How to Access

Pharmaceutical operators must comply with these guidelines as a condition of their NAFDAC registration. Obtain guidelines from NAFDAC during registration or renewal Access through the Pharmacists Council of Nigeria Available at pharmaceutical industry training workshops

Important Terms

Compliance: Non-compliance can result in suspension or revocation of distribution licenses Inspection: Facilities are subject to scheduled and unannounced NAFDAC inspections Reporting: Adverse events and quality issues must be reported to NAFDAC

Official Resources

Website: nafdac.gov.ng Contact: NAFDAC Headquarters, Abuja

Legal Framework

The National Drug Distribution Guidelines are issued under the NAFDAC Act and operate alongside the Pharmacy Council of Nigeria Act, the National Drug Policy, and the Public Procurement Act 2007 (on pharmaceutical procurement). International alignment is with WHO Good Distribution Practices for Pharmaceutical Products, the Global Fund Supply Chain Management standards, and the Partnership for Supply Chain Management (PFSCM) pharmaceutical distribution guidelines.